Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems

Clinical trial NCT00238355 · TERMINATED

Trial details

NCT number: NCT00238355
Sponsor: OHSU Knight Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Infection Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2003-08-01
Primary completion: 2008-06-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.